Dalles Andre
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 10%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 detection and testing 2
- Viral gastroenteritis research and epidemiology 1
-
- Animal Virus Infections Studies 5
- Journals
- mBio (3 papers)Nature Communications (2 papers)Cancer Cell (2 papers)Immunity (1 paper)Cell Reports Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Dalles Andre
10 papers receiving 407 citations
Dalles Andre's Hit Papers
Peers
Comparison fields: 5 of 40
- Infectious Diseases 297
- Modeling and Simulation 22
- Animal Science and Zoology 39
- Immunology 72
- Health 25
Countries citing papers authored by Dalles Andre
This map shows the geographic impact of Dalles Andre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalles Andre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalles Andre more than expected).
Fields of papers citing papers by Dalles Andre
This network shows the impact of papers produced by Dalles Andre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalles Andre. The network helps show where Dalles Andre may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 121 | |
| 2 | SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase Hit paper breakdown → | 2024 | 87 |
| 3 | 2021 | 66 | |
| 4 | 2023 | 58 | |
| 5 | 2022 | 33 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 8 | |
| 9 | 2023 | 7 | |
| 10 | 2024 | 4 |
About Dalles Andre
Dalles Andre is a scholar working on Infectious Diseases, Animal Science and Zoology, Immunology, Ophthalmology and Epidemiology, having authored 10 papers that have together received 412 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers), Animal Virus Infections Studies (5 papers), Immunotherapy and Immune Responses (3 papers), SARS-CoV-2 detection and testing (2 papers), Viral gastroenteritis research and epidemiology (1 paper), Retinal and Optic Conditions (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Infectious Diseases (297 citations), Modeling and Simulation (22 citations), Animal Science and Zoology (39 citations), Immunology (72 citations) and Health (25 citations). Dalles Andre has collaborated with scholars based in United States. Their work appears in journals such as mBio, Nature Communications, Cancer Cell, Immunity and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.